Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
The Scientist
Most Recent
Industry experts discuss the agency’s plans to make the drug approval process more transparent.
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
Rising ocean acidity along the California coast may wreak havoc in the region’s oyster populations.
Grasshoppers in fear of predation die with less nitrogen in their bodies than unstressed grasshoppers, which can affect soil ecology.
Algal blooms are appearing under the ice in the Arctic Ocean in areas thought to receive too little light to support photosynthetic life.
Shortly after a rat infested supply ship ran aground in Lord Howe Island off the east coast of Australia in 1918, the newly introduced mammals wiped out the island's phasmids—stick insects the size of a human hand. Ever since, phasmids have been cons
The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.
Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of d
Gene therapies typically involve the introduction of genetic material into target cells to replace or supplement an existing, usually dysfunctional, gene. Techniques for delivering the corrective payload vary widely. Many gene therapies utilize modif
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
